The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2023 | Highlights from ELCC 2023
Jessica Menis, MD, AOU Integrata di Verona, Verona, Italy, discusses highlights from the European Lung Cancer Congress (ELCC) 2023 meeting, including adjuvant and neoadjuvant treatment strategies, as well as upcoming trial results evaluating targeted therapies. This interview took place at the European Lung Cancer Congress 2023 in Copenhagen, Denmark.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
